Driven. For a Sustainable Life.
-
“We’re committed to advancing sustainable operations
for the betterment of society, global health, and the planet"We embrace accountability by integrating environmentally conscious strategies and upholding the highest ethical standards throughout our entire operations.
Through responsible practices we strengthen our supply chain, support communities, and minimize environmental impact—driving progress for society, global health, and our planet. We create meaningful impact by enhancing social engagement, strengthening our governance, and reducing our environmental footprint.
- TERRA CARTA
- Samsung Biologics was awarded the Terra Carta Seal, which recognizes global companies that are actively leading the charge to create a climate-positive future through tangible organization-wide efforts.
Our Focus Areas
Our Contributions to Global Initiatives
We take an active role in collaborative initiatives that help shape policy and drive change across the pharmaceutical and healthcare sectors. This includes participating in global frameworks such as the United Nations Sustainable Development Goals and advancing efforts in sustainable aviation, as well as contributing to industry ratings and awards.
Most notably, Samsung Biologics champions the Sustainable Markets Initiative Supply Chain Working Group, driving collaborative action on sustainable value chains and accelerating the delivery of net-zero healthcare.
Ratings and Awards
Awarded the Gold Sustainability Rating from EcoVadis in 2025
Terra Carta Seal
Awarded the 2022 Terra Carta Seal
Received Leadership status for Water Security and B rating for Climate Change
Achieved MSCI ESG Rating of BBB in 2025
Listed by the DJSI World, Asia Pacific, & Korea Indices for 5 consecutive years
Received an overall ‘Low Risk’ rating from Sustainalytics for 3 consecutive years
Recognized as an industry Top-Rated company
Global Initiatives
Joined the Sustainable Aviation Buyers Alliance
Helping reduce emissions through investment in Sustainable Aviation Fuel
Pharmaceutical Supply Chain Initiative (PSCI)
July 2024, The First Supplier Signatory among CDMOs
Declaration in support of the TCFD (Jul 2022) & first TCFD Report published (Dec 2022)
Joined RE100 (Nov 2022)
Declared Net Zero targets for Scopes 1 and 2 by 2050
United Nations SDGs (Sustainable Development Goals) Supporter
Joined the UNGC (United Nations Global Compact) (Jun 2023)
Member of the Sustainable Markets Initiative (led by King Charles III)
Supply Chains Working Group championed by John Rim, CEO of Samsung Biologics
International Certifications and Standards
-
-
ISO 9001
- Quality Management System
-
-
-
ISO 14001
- Environmental Management System
-
-
-
ISO 22301
- Business Continuity Management System
-
-
-
ISO 27001
- Information Security Management System
-
-
-
ISO 27017
- Information Security in Cloud Services
-
-
-
ISO 37001
- Anti-bribery Management Systems
-
-
-
ISO 37301
- Compliance Management Systems
-
-
-
ISO 45001
- Safety & Health Management System
-
-
-
ISO 50001
- Energy Management System
-
Related Content